Yao Y - Search Results

1

The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.

Lin SC, Gan ZH, Yao Y, Min da L. Lin SC, et al. Among authors: yao y. PLoS One. 2015 Aug 25;10(8):e0136374. doi: 10.1371/journal.pone.0136374. eCollection 2015. PLoS One. 2015. PMID: 26305693 Free PMC article.

2

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Among authors: yao y. Br J Clin Pharmacol. 2013 Apr;75(4):919-30. doi: 10.1111/j.1365-2125.2012.04417.x. Br J Clin Pharmacol. 2013. PMID: 22882307 Free PMC article. Review.

3

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.

Min D, Lin F, Shen Z, Zheng S, Tan L, Yu W, Yao Y. Min D, et al. Among authors: yao y. Asia Pac J Clin Oncol. 2013 Mar;9(1):71-9. doi: 10.1111/j.1743-7563.2012.01560.x. Epub 2012 Jul 23. Asia Pac J Clin Oncol. 2013. PMID: 22897971

4

Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trials.

Qi WX, Tang LN, He AN, Shen Z, Yao Y. Qi WX, et al. Among authors: yao y. Breast. 2013 Jun;22(3):314-9. doi: 10.1016/j.breast.2012.07.014. Epub 2012 Aug 14. Breast. 2013. PMID: 22901442 Free article.

5

Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis.

Qi WX, Lin F, Sun YJ, Tang LN, He AN, Yao Y, Shen Z. Qi WX, et al. Among authors: yao y. Cancer Chemother Pharmacol. 2013 Feb;71(2):431-9. doi: 10.1007/s00280-012-2025-5. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178953

6

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Among authors: yao y. Curr Med Res Opin. 2013 Feb;29(2):117-25. doi: 10.1185/03007995.2012.756393. Epub 2012 Dec 26. Curr Med Res Opin. 2013. PMID: 23216340 Review.

7

Overall survival benefits for combining targeted therapy as second-line treatment for advanced non-small-cell-lung cancer: a meta-analysis of published data.

Qi WX, Wang Q, Jiang YL, Sun YJ, Tang LN, He AN, Min DL, Lin F, Shen Z, Yao Y. Qi WX, et al. Among authors: yao y. PLoS One. 2013;8(2):e55637. doi: 10.1371/journal.pone.0055637. Epub 2013 Feb 8. PLoS One. 2013. PMID: 23409011 Free PMC article.

8

Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis.

Huang YJ, Qi WX, He AN, Sun YJ, Shen Z, Yao Y. Huang YJ, et al. Among authors: yao y. Asian Pac J Cancer Prev. 2013;14(2):645-9. doi: 10.7314/apjcp.2013.14.2.645. Asian Pac J Cancer Prev. 2013. PMID: 23621212 Free article.

9

Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysis.

Qi WX, Huang YJ, Yao Y, Shen Z, Min DL. Qi WX, et al. Among authors: yao y. PLoS One. 2013 Jun 13;8(6):e65166. doi: 10.1371/journal.pone.0065166. Print 2013. PLoS One. 2013. PMID: 23785409 Free PMC article.

10

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.

Li H, Min D, Zhao H, Wang Z, Qi W, Zheng S, Tang L, He A, Sun Y, Yao Y, Shen Z. Li H, et al. Among authors: yao y. PLoS One. 2013 Jun 21;8(6):e64513. doi: 10.1371/journal.pone.0064513. Print 2013. PLoS One. 2013. PMID: 23805177 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,649 results

Search Page

Filters